Welcome to the ADCES Media Center
Find the latest information from reputable sources for your news stories about diabetes care and education.
Media Relations
ADCES Media Center
The Association of Diabetes Care & Education Specialists is home to experts on various topics related to diabetes care and education. We welcome the opportunity to provide you with sources and resources about what we do and the impact we have on people with diabetes and the healthcare system.
Media Contact
For more information, contact Sloane Fisher in ADCES® Media Relations at media@adces.org.
Talking About Diabetes
Language & Diabetes in the Media
How we talk about diabetes in the media has an impact. Using descriptive and non-judgmental language when talking about diabetes or about people with diabetes can make a positive difference. If you’re a member of the media, please take a moment to review these suggestions when covering stories on diabetes.
Quotes From Diabetes Spokespeople
Get expert commentary, story ideas and background information on the full range of prediabetes, diabetes and cardiometabolic related topics from ADCES volunteer diabetes spokespeople. If you’re writing an article on any of these subjects, consider interviewing one of our qualified diabetes care and education experts.
ADCES & Diabetes in the Media
Learn more about ADCES’s contributions, activities and events surrounding the education, management and prevention of prediabetes, diabetes and related cardiometabolic conditions in our latest news releases.
ADCES names Rachel Stahl Salzman 2027 Diabetes Care and Education Specialist of the Year
COLUMBUS, OH, and CHICAGO, IL — The Association of Diabetes Care & Education Specialists (ADCES) is pleased to announce that Rachel Stahl Salzman, MS, RDN, CDN, CDCES, has been selected as the recipient of the 2027 Diabetes Care and Education Specialist of the Year Award, sponsored by Xeris Pharmaceuticals, Inc.
Salzman is a Lecturer in Medicine and certified diabetes care and education specialist (CDCES) Lead at Weill Cornell Medicine in New York City. She is dedicated to helping people with diabetes achieve sustainable lifestyle changes and effectively use diabetes technology to improve their health and quality of life.
The Diabetes Care and Education Specialist of the Year Award recognizes a diabetes care and education specialist who has made exceptional contributions to the field through dedication, innovation, and compassionate, person-centered care.
In addition to her clinical work, Salzman serves as President of the ADCES Metropolitan New York Local Networking Group, where she fosters collaboration and professional engagement among diabetes care and education specialists. She was selected for her compassionate, evidence-based approach to care, her commitment to mentoring the next generation of healthcare professionals, and her leadership in quality improvement and research. Through her clinical expertise, education, advocacy, and leadership, Salzman exemplifies the highest standards of the diabetes care and education specialty.
About The Association of Diabetes Care & Education Specialists
ADCES is an interdisciplinary professional membership organization dedicated to improving prediabetes, diabetes and cardiometabolic care through innovative education, management and support. With more than 11,000 professional members including nurses, dietitians, pharmacists and others, ADCES has a vast network of practitioners working to optimize care and reduce complications. ADCES supports an integrated care model that lowers the cost of care, improves experiences and helps its members lead so better outcomes follow. Learn more at adces.org or visit us on Facebook or LinkedIn (Association of Diabetes Care & Education Specialists), X (@ADCESdiabetes) and Instagram (@ADCESdiabetes).
About Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), is a fast-growing biopharmaceutical company dedicated to improving patients’ lives through the development and commercialization of innovative therapies. Xeris markets three products treating severe hypoglycemia, endogenous Cushing’s syndrome, and primary periodic paralysis, while advancing a pipeline of internal and partnered programs enabled by its proprietary formulation science.
Xeris Biopharma Holdings, Inc. is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.
Leave a comment